VENLAFAXINE

VENLAFAXINE was reported 133443 times

VENLAFAXINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 AMYLOID ARTHROPATHY 65 0.9286
1 MALIGNANT MEDIASTINAL NEOPLASM 51 0.4636
2 INSPIRATORY CAPACITY DECREASED 105 0.3791
3 ANTIDEPRESSANT DISCONTINUATION SYNDROME 64 0.3048
4 NEOVASCULARISATION 59 0.2243
5 AMAUROSIS FUGAX 221 0.2052
6 ANTIDEPRESSANT DRUG LEVEL ABOVE THERAPEUTIC 48 0.1853
7 POSTMORTEM BLOOD DRUG LEVEL INCREASED 56 0.1501
8 TEMPERATURE REGULATION DISORDER 331 0.1484
9 SELECTIVE EATING DISORDER 122 0.1341
10 RESPIRATORY DISORDER NEONATAL 216 0.1332
11 PHYSICAL DECONDITIONING 301 0.1168
12 SEROTONIN SYNDROME 2165 0.1126
13 BRADYCARDIA NEONATAL 138 0.1097
14 HYPOTONIA NEONATAL 167 0.1068
15 AGITATION NEONATAL 90 0.0938
16 INFANTILE APNOEA 65 0.0797
17 NEONATAL ASPHYXIA 56 0.0790
18 FOETAL DEATH 404 0.0778
19 SOCIAL ANXIETY DISORDER 51 0.0776
20 BEZOAR 107 0.0775
21 ELECTRIC SHOCK SENSATION 216 0.0771
22 POISONING DELIBERATE 728 0.0767
23 MAJOR DEPRESSION 509 0.0696
24 MULTIPLE DRUG THERAPY 51 0.0676
25 SOFT TISSUE INJURY 49 0.0647
26 NEONATAL RESPIRATORY DISTRESS 60 0.0636
27 DRUG SPECIFIC ANTIBODY 87 0.0635
28 VICTIM OF CRIME 78 0.0631
29 NEONATAL HYPOXIA 52 0.0629
30 INTRUSIVE THOUGHTS 71 0.0603
31 CATAPLEXY 85 0.0600
32 HYPERREFLEXIA 207 0.0594
33 MEDICATION OVERUSE HEADACHE 50 0.0584
34 LARGE FOR DATES BABY 51 0.0578
35 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 114 0.0577
36 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 51 0.0573
37 SLEEP-RELATED EATING DISORDER 52 0.0555
38 SMALL FOR DATES BABY 274 0.0551
39 EMOTIONAL POVERTY 96 0.0547
40 FOOD ALLERGY 418 0.0541
41 CLONUS 148 0.0540
42 URINARY TRACT DISORDER 225 0.0499
43 COMA SCALE ABNORMAL 135 0.0466
44 ACCIDENTAL DEATH 86 0.0462
45 PRODUCT USED FOR UNKNOWN INDICATION 57 0.0453
46 ANTICHOLINERGIC SYNDROME 72 0.0452
47 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 229 0.0446
48 PSYCHOTIC SYMPTOM 92 0.0445
49 SLEEP PARALYSIS 65 0.0442
50 PULMONARY PAIN 129 0.0441
51 INAPPROPRIATE AFFECT 70 0.0441
52 GESTATIONAL DIABETES 205 0.0430
53 STRESS CARDIOMYOPATHY 241 0.0414
54 DEREALISATION 89 0.0413
55 COMPLETED SUICIDE 3361 0.0403
56 FEELINGS OF WORTHLESSNESS 52 0.0398
57 MYDRIASIS 511 0.0398
58 BLOOD PRESSURE SYSTOLIC ABNORMAL 96 0.0388
59 ATRIAL SEPTAL DEFECT 325 0.0388
60 INTENTIONAL OVERDOSE 2482 0.0387
61 ISCHAEMIC HEPATITIS 52 0.0380
62 SUICIDE ATTEMPT 2261 0.0373
63 SUSPECTED SUICIDE 174 0.0371
64 BLOOD PRESSURE DIASTOLIC ABNORMAL 93 0.0365
65 SEDATION 915 0.0349
66 PSYCHOMOTOR RETARDATION 98 0.0348
67 LIBIDO INCREASED 70 0.0345
68 HYPOMANIA 125 0.0340
69 ALCOHOL INTERACTION 65 0.0334
70 SOPOR 443 0.0334
71 PERSONALITY DISORDER 87 0.0332
72 HAEMORRHAGIC STROKE 254 0.0325
73 ANORGASMIA 88 0.0324
74 NEONATAL RESPIRATORY DISTRESS SYNDROME 114 0.0322
75 COMA 1474 0.0309
76 CARDIOGENIC SHOCK 442 0.0308
77 INTENTIONAL SELF-INJURY 617 0.0305
78 IMMUNODEFICIENCY 446 0.0299
79 GENERALISED TONIC-CLONIC SEIZURE 490 0.0296
80 DEPRESSIVE SYMPTOM 104 0.0295
81 HOMICIDE 53 0.0287
82 ELECTROCARDIOGRAM QT PROLONGED 1025 0.0285
83 MYOCLONUS 337 0.0282
84 ALTERED STATE OF CONSCIOUSNESS 609 0.0281
85 PATENT DUCTUS ARTERIOSUS 111 0.0279
86 TEARFULNESS 120 0.0279
87 POISONING 347 0.0276
88 VENTRICULAR SEPTAL DEFECT 158 0.0276
89 COLITIS MICROSCOPIC 129 0.0272
90 TOXICITY TO VARIOUS AGENTS 4577 0.0271
91 ANTIPSYCHOTIC DRUG LEVEL INCREASED 76 0.0270
92 NIGHTMARE 934 0.0270
93 VENTRICULAR DYSFUNCTION 70 0.0270
94 COELIAC DISEASE 263 0.0268
95 HOSTILITY 68 0.0267
96 TALIPES 83 0.0267
97 LOGORRHOEA 93 0.0264
98 SUBSTANCE USE DISORDER 84 0.0263
99 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 70 0.0263
100 PERSECUTORY DELUSION 65 0.0260
101 BLOOD IMMUNOGLOBULIN E INCREASED 63 0.0260
102 WITHDRAWAL SYNDROME 1085 0.0258
103 IMPULSIVE BEHAVIOUR 95 0.0253
104 DISTRIBUTIVE SHOCK 57 0.0251
105 HALLUCINATIONS, MIXED 105 0.0249
106 PARADOXICAL DRUG REACTION 91 0.0247
107 FULL BLOOD COUNT ABNORMAL 260 0.0246
108 OCULAR DISCOMFORT 272 0.0242
109 SINUS TACHYCARDIA 342 0.0241
110 CARDIO-RESPIRATORY ARREST 1006 0.0240
111 ENDOMETRIOSIS 114 0.0239
112 PRESCRIBED OVERDOSE 461 0.0238
113 NEUROLEPTIC MALIGNANT SYNDROME 281 0.0237
114 BURSITIS 284 0.0234
115 CARDIOTOXICITY 205 0.0230
116 AKATHISIA 312 0.0228
117 HEAD DISCOMFORT 396 0.0223
118 PULSELESS ELECTRICAL ACTIVITY 93 0.0222
119 RESPIRATORY DEPRESSION 271 0.0221
120 ALCOHOL POISONING 59 0.0220
121 METABOLIC ACIDOSIS 702 0.0219
122 SUICIDAL IDEATION 1991 0.0217
123 RESPIRATORY ACIDOSIS 85 0.0216
124 DRUG USE DISORDER 181 0.0215
125 HYPERTONIC BLADDER 62 0.0214
126 DRUG ABUSE 1777 0.0213
127 PARKINSONISM 208 0.0213
128 VENTRICULAR HYPOKINESIA 68 0.0212
129 DRUG INTERACTION 3354 0.0211
130 LEFT VENTRICULAR DYSFUNCTION 141 0.0210
131 SLOW SPEECH 51 0.0210
132 DISSOCIATION 160 0.0208
133 HEPATIC NECROSIS 78 0.0207
134 MIOSIS 166 0.0207
135 MUSCLE RIGIDITY 247 0.0206
136 CATATONIA 108 0.0205
137 CEREBRAL HAEMATOMA 69 0.0205
138 NEGATIVE THOUGHTS 60 0.0205
139 BRUXISM 110 0.0204
140 BRADYPNOEA 55 0.0204
141 TACHYPHRENIA 70 0.0202
142 REBOUND ACID HYPERSECRETION 61 0.0201
143 GAMBLING DISORDER 54 0.0200
144 HALLUCINATION, VISUAL 422 0.0200
145 POTENTIATING DRUG INTERACTION 67 0.0199
146 PANIC DISORDER 77 0.0199
147 NYSTAGMUS 105 0.0198
148 BRAIN DEATH 61 0.0197
149 SEXUAL DYSFUNCTION 230 0.0196
150 MIXED LIVER INJURY 59 0.0196
151 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 201 0.0196
152 PSYCHOMOTOR SKILLS IMPAIRED 51 0.0195
153 DEPRESSION SUICIDAL 67 0.0193
154 SELF INJURIOUS BEHAVIOUR 59 0.0193
155 GENERALISED OEDEMA 238 0.0192
156 VENTRICULAR ARRHYTHMIA 70 0.0191
157 HALLUCINATION, AUDITORY 304 0.0191
158 PRE-ECLAMPSIA 90 0.0189
159 SELF-INJURIOUS IDEATION 79 0.0188
160 SUICIDAL BEHAVIOUR 78 0.0187
161 HYPERTHERMIA 143 0.0187
162 MANIA 308 0.0187
163 LEFT VENTRICULAR HYPERTROPHY 80 0.0187
164 HYPERHIDROSIS 2393 0.0186
165 FOETAL EXPOSURE DURING PREGNANCY 1503 0.0185
166 CONGESTIVE CARDIOMYOPATHY 77 0.0185
167 FORCED EXPIRATORY VOLUME DECREASED 52 0.0183
168 PHOTOPHOBIA 334 0.0177
169 HYPERTONIA 101 0.0176
170 BLOOD PRESSURE DIASTOLIC INCREASED 81 0.0175
171 HYPERACUSIS 65 0.0174
172 LOSS OF LIBIDO 157 0.0174
173 BRADYKINESIA 102 0.0173
174 STUPOR 55 0.0171
175 BLOOD LACTIC ACID INCREASED 89 0.0169
176 DRUG LEVEL ABOVE THERAPEUTIC 77 0.0168
177 DELUSION 259 0.0167
178 NEPHROGENIC ANAEMIA 76 0.0164
179 BRADYPHRENIA 107 0.0164
180 VENTRICULAR TACHYCARDIA 268 0.0162
181 ANXIETY DISORDER 54 0.0161
182 SOMNAMBULISM 106 0.0161
183 APATHY 235 0.0161
184 HYPOTHERMIA 163 0.0161
185 INTESTINAL ISCHAEMIA 88 0.0160
186 RESTLESSNESS 584 0.0159
187 RESTLESS LEGS SYNDROME 285 0.0157
188 BEHAVIOUR DISORDER 84 0.0155
189 CONCUSSION 120 0.0155
190 DRUG WITHDRAWAL SYNDROME NEONATAL 227 0.0153
191 TACHYCARDIA 1360 0.0153
192 BRONCHIECTASIS 103 0.0153
193 DECREASED INTEREST 90 0.0152
194 DRUG LEVEL INCREASED 251 0.0151
195 HYPERNATRAEMIA 75 0.0150
196 EXPOSURE DURING PREGNANCY 935 0.0150
197 AGITATION 1101 0.0150
198 DIPLOPIA 389 0.0150
199 DEPRESSED LEVEL OF CONSCIOUSNESS 591 0.0149
200 TORSADE DE POINTES 117 0.0149
201 BODY TEMPERATURE DECREASED 146 0.0148
202 BLOOD PRESSURE SYSTOLIC INCREASED 289 0.0148
203 HYPERPROLACTINAEMIA 96 0.0148
204 PSYCHOMOTOR HYPERACTIVITY 245 0.0147
205 SUBSTANCE ABUSE 120 0.0147
206 GALACTORRHOEA 94 0.0146
207 HAEMODYNAMIC INSTABILITY 111 0.0146
208 EXPOSURE VIA BREAST MILK 58 0.0146
209 AFFECTIVE DISORDER 114 0.0145
210 ANURIA 124 0.0144
211 DEPRESSED MOOD 759 0.0143
212 STATUS EPILEPTICUS 162 0.0143
213 HOMICIDAL IDEATION 58 0.0143
214 TENSION 87 0.0143
215 HEPATIC FIBROSIS 49 0.0143
216 EUPHORIC MOOD 145 0.0141
217 RESPIRATORY ARREST 389 0.0141
218 PNEUMONIA ASPIRATION 352 0.0141
219 HAEMATEMESIS 355 0.0140
220 ACIDOSIS 107 0.0140
221 SOCIAL AVOIDANT BEHAVIOUR 81 0.0140
222 SLEEP TERROR 58 0.0138
223 MUSCLE TWITCHING 317 0.0137
224 HEPATOCELLULAR INJURY 194 0.0137
225 ACUTE RESPIRATORY DISTRESS SYNDROME 242 0.0137
226 BLOOD PRESSURE DIASTOLIC DECREASED 101 0.0137
227 ENURESIS 55 0.0136
228 PSYCHIATRIC SYMPTOM 100 0.0135
229 DISTURBANCE IN ATTENTION 729 0.0135
230 CONTRAINDICATED PRODUCT ADMINISTERED 404 0.0133
231 OBSESSIVE-COMPULSIVE DISORDER 107 0.0133
232 SNORING 50 0.0132
233 PRESYNCOPE 320 0.0131
234 MENTAL IMPAIRMENT 319 0.0131
235 HYPOTONIA 131 0.0131
236 HEPATIC CYTOLYSIS 167 0.0131
237 EXTRAPYRAMIDAL DISORDER 325 0.0131
238 BIPOLAR DISORDER 141 0.0130
239 PARANOIA 223 0.0129
240 DRUG INTOLERANCE 1246 0.0129
241 FEELING OF DESPAIR 60 0.0129
242 EYE MOVEMENT DISORDER 88 0.0128
243 OBSTRUCTIVE AIRWAYS DISORDER 142 0.0128
244 CARDIAC FAILURE ACUTE 85 0.0127
245 LACTIC ACIDOSIS 413 0.0127
246 URINARY INCONTINENCE 377 0.0127
247 SKIN ABRASION 60 0.0127
248 SWOLLEN TONGUE 395 0.0126
249 ASPHYXIA 103 0.0126
250 TENSION HEADACHE 54 0.0125
251 UNRESPONSIVE TO STIMULI 323 0.0125
252 ANAL FISSURE 67 0.0125
253 ERECTILE DYSFUNCTION 320 0.0124
254 ENCEPHALOPATHY 306 0.0124
255 ANAL INCONTINENCE 112 0.0124
256 DYSPHORIA 63 0.0124
257 MATERNAL DRUGS AFFECTING FOETUS 95 0.0124
258 SPINAL STENOSIS 51 0.0123
259 SCHIZOPHRENIA 150 0.0123
260 THINKING ABNORMAL 227 0.0122
261 OVERDOSE 2628 0.0122
262 NEPHROLITHIASIS 558 0.0122
263 TINNITUS 558 0.0121
264 DELIRIUM 421 0.0121
265 INTENTIONAL PRODUCT MISUSE 1060 0.0121
266 ORTHOSTATIC HYPOTENSION 209 0.0120
267 APHTHOUS ULCER 93 0.0120
268 BUNDLE BRANCH BLOCK RIGHT 55 0.0120
269 DEPRESSION 2711 0.0119
270 CRYING 429 0.0118
271 COORDINATION ABNORMAL 164 0.0117
272 HYPERVENTILATION 68 0.0117
273 RHABDOMYOLYSIS 488 0.0117
274 HYPONATRAEMIA 658 0.0117
275 COGNITIVE DISORDER 543 0.0116
276 PSYCHOTIC DISORDER 342 0.0116
277 PANIC ATTACK 422 0.0116
278 FOETAL GROWTH RESTRICTION 69 0.0113
279 POST-TRAUMATIC STRESS DISORDER 76 0.0113
280 FEELING DRUNK 84 0.0113
281 ATAXIA 133 0.0112
282 SALIVARY HYPERSECRETION 112 0.0112
283 CARDIAC ARREST 922 0.0112
284 SOMNOLENCE 2225 0.0110
285 ASPIRATION 121 0.0110
286 DYSKINESIA 447 0.0110
287 CIRCULATORY COLLAPSE 186 0.0109
288 SLEEP APNOEA SYNDROME 208 0.0109
289 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 96 0.0108
290 VENTRICULAR FIBRILLATION 120 0.0108
291 SEIZURE 1246 0.0108
292 HYPERTRIGLYCERIDAEMIA 63 0.0108
293 DISORIENTATION 424 0.0107
294 COLITIS ISCHAEMIC 72 0.0107
295 ACUTE KIDNEY INJURY 1633 0.0107
296 INCOHERENT 69 0.0106
297 GASTROINTESTINAL MOTILITY DISORDER 57 0.0106
298 IMPAIRED QUALITY OF LIFE 153 0.0106
299 FOOD CRAVING 56 0.0106
300 POOR QUALITY SLEEP 229 0.0106
301 LIGAMENT SPRAIN 105 0.0106
302 MICTURITION URGENCY 121 0.0106
303 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 581 0.0106
304 MIDDLE INSOMNIA 196 0.0105
305 TREMOR 1735 0.0104
306 INCREASED TENDENCY TO BRUISE 96 0.0104
307 INCONTINENCE 110 0.0104
308 DECREASED IMMUNE RESPONSIVENESS 102 0.0104
309 PANIC REACTION 75 0.0104
310 BRAIN INJURY 104 0.0104
311 ANGER 350 0.0103
312 RASH ERYTHEMATOUS 494 0.0103
313 NEUROLOGICAL SYMPTOM 59 0.0103
314 BODY TEMPERATURE INCREASED 210 0.0103
315 TROPONIN INCREASED 78 0.0102
316 CONCOMITANT DISEASE AGGRAVATED 63 0.0102
317 INFUSION RELATED REACTION 675 0.0102
318 PRODUCT SUBSTITUTION ISSUE 585 0.0102
319 CARDIOMYOPATHY 149 0.0101
320 HYPOKINESIA 146 0.0100
321 RESPIRATORY RATE INCREASED 89 0.0100
322 BRAIN FOG 157 0.0100
323 CONFUSIONAL STATE 1608 0.0099
324 ASCITES 292 0.0099
325 CARDIOMEGALY 122 0.0099
326 URINARY RETENTION 330 0.0099
327 MULTIPLE ORGAN DYSFUNCTION SYNDROME 280 0.0099
328 HYPOPHOSPHATAEMIA 73 0.0099
329 NEUTROPHIL COUNT INCREASED 101 0.0099
330 ARTERIOSCLEROSIS CORONARY ARTERY 65 0.0098
331 UPPER RESPIRATORY TRACT INFECTION 452 0.0098
332 HEPATIC ENZYME INCREASED 664 0.0097
333 DYSARTHRIA 366 0.0097
334 ASTHMA 1095 0.0097
335 ELECTROCARDIOGRAM ABNORMAL 76 0.0097
336 TOXIC ENCEPHALOPATHY 49 0.0097
337 ANGIOEDEMA 427 0.0096
338 MENTAL DISORDER 418 0.0096
339 CEREBRAL DISORDER 71 0.0096
340 CHRONIC KIDNEY DISEASE 729 0.0096
341 HEPATIC STEATOSIS 178 0.0095
342 HYPOGLYCAEMIA 461 0.0095
343 APPETITE DISORDER 63 0.0095
344 BLOOD PRESSURE FLUCTUATION 228 0.0095
345 AGGRESSION 474 0.0095
346 EJECTION FRACTION DECREASED 147 0.0094
347 RESPIRATORY DISTRESS 259 0.0094
348 ON AND OFF PHENOMENON 52 0.0094
349 ANXIETY 2662 0.0093
350 AFFECT LABILITY 90 0.0093
351 FACIAL PAIN 83 0.0093
352 OXYGEN SATURATION DECREASED 520 0.0092
353 OLIGURIA 57 0.0092
354 MIGRAINE 874 0.0091
355 FAECALOMA 50 0.0091
356 TYPE 2 DIABETES MELLITUS 303 0.0090
357 HYPERTENSIVE CRISIS 100 0.0090
358 HYPOMAGNESAEMIA 125 0.0090
359 HALLUCINATION 675 0.0089
360 BALANCE DISORDER 773 0.0089
361 HYPERSOMNIA 256 0.0089
362 OBESITY 142 0.0089
363 BLEPHAROSPASM 56 0.0089
364 HYPOVOLAEMIA 52 0.0089
365 SLEEP DISORDER 627 0.0089
366 PULMONARY CONGESTION 117 0.0089
367 HYDROCEPHALUS 48 0.0088
368 EPILEPSY 267 0.0087
369 ABNORMAL DREAMS 240 0.0087
370 SINUS BRADYCARDIA 84 0.0087
371 CHOLESTASIS 165 0.0086
372 DIZZINESS POSTURAL 83 0.0086
373 VERTIGO 521 0.0085
374 ANHEDONIA 223 0.0085
375 SHOCK 194 0.0084
376 TREATMENT FAILURE 697 0.0084
377 POOR VENOUS ACCESS 87 0.0084
378 POLYP 55 0.0084
379 DRUG-INDUCED LIVER INJURY 263 0.0084
380 SENSORY LOSS 67 0.0083
381 SUDDEN DEATH 88 0.0083
382 MUSCLE SPASTICITY 102 0.0083
383 FRUSTRATION TOLERANCE DECREASED 67 0.0083
384 PERSONALITY CHANGE 77 0.0083
385 MYOCARDITIS 95 0.0083
386 BRADYCARDIA 439 0.0083
387 AMNESIA 538 0.0083
388 END STAGE RENAL DISEASE 150 0.0082
389 IRRITABILITY 493 0.0082
390 HYPERAESTHESIA 67 0.0081
391 RENAL TUBULAR NECROSIS 80 0.0081
392 HEPATIC ENCEPHALOPATHY 76 0.0081
393 MOUTH ULCERATION 171 0.0081
394 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 139 0.0081
395 HYPERTENSION 1710 0.0081
396 HAEMATURIA 276 0.0081
397 ACUTE HEPATIC FAILURE 110 0.0080
398 RIB FRACTURE 165 0.0080
399 LOWER RESPIRATORY TRACT INFECTION 364 0.0080
400 POSTOPERATIVE WOUND INFECTION 54 0.0080
401 INSOMNIA 2127 0.0080
402 RESPIRATION ABNORMAL 55 0.0080
403 BLINDNESS 325 0.0080
404 MOOD SWINGS 254 0.0080
405 PYELONEPHRITIS 69 0.0080
406 NIGHT SWEATS 255 0.0079
407 IRON DEFICIENCY ANAEMIA 73 0.0079
408 BLOOD PRESSURE INCREASED 1208 0.0079
409 PSYCHOLOGICAL TRAUMA 68 0.0079
410 MITRAL VALVE INCOMPETENCE 89 0.0079
411 DRUG LEVEL DECREASED 80 0.0079
412 FIBROMYALGIA 191 0.0078
413 FLUID RETENTION 399 0.0078
414 NEUTROPENIC SEPSIS 56 0.0078
415 ANKYLOSING SPONDYLITIS 103 0.0078
416 DYSPHONIA 456 0.0078
417 IMPAIRED GASTRIC EMPTYING 106 0.0078
418 PRODUCT ADMINISTRATION INTERRUPTED 61 0.0078
419 RETCHING 165 0.0077
420 FAECES SOFT 56 0.0077
421 DRUG SPECIFIC ANTIBODY PRESENT 50 0.0077
422 HYPOTENSION 1534 0.0076
423 HAIR DISORDER 63 0.0076
424 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 366 0.0076
425 FALL 2536 0.0076
426 DEFAECATION URGENCY 53 0.0076
427 BRAIN OEDEMA 95 0.0075
428 HEART RATE DECREASED 264 0.0075
429 DRUG WITHDRAWAL SYNDROME 659 0.0075
430 IMPAIRED WORK ABILITY 160 0.0075
431 MOVEMENT DISORDER 240 0.0075
432 BLOOD CREATINE PHOSPHOKINASE INCREASED 215 0.0075
433 QUALITY OF LIFE DECREASED 100 0.0074
434 GASTROINTESTINAL PAIN 82 0.0074
435 THERAPY NON-RESPONDER 335 0.0074
436 CLOSTRIDIUM DIFFICILE COLITIS 79 0.0074
437 SWELLING FACE 485 0.0074
438 SENSORY DISTURBANCE 119 0.0074
439 DRUG TOXICITY 101 0.0074
440 MEMORY IMPAIRMENT 1016 0.0074
441 LOSS OF CONSCIOUSNESS 945 0.0074
442 SPEECH DISORDER 386 0.0074
443 SUBARACHNOID HAEMORRHAGE 75 0.0074
444 PERIPHERAL COLDNESS 101 0.0073
445 FEELING JITTERY 140 0.0073
446 DRY MOUTH 595 0.0073
447 EAR PAIN 142 0.0073
448 HYPERGLYCAEMIA 266 0.0073
449 HEART RATE INCREASED 720 0.0073
450 WRONG PRODUCT ADMINISTERED 49 0.0072
451 PREMATURE BABY 218 0.0072
452 NERVOUS SYSTEM DISORDER 226 0.0072
453 HOT FLUSH 545 0.0072
454 GENERAL PHYSICAL CONDITION ABNORMAL 49 0.0072
455 DRUG SCREEN POSITIVE 57 0.0072
456 ABNORMAL LOSS OF WEIGHT 49 0.0072
457 MENTAL STATUS CHANGES 199 0.0072
458 EXTRASYSTOLES 50 0.0072
459 SYNCOPE 716 0.0071
460 EYE PAIN 403 0.0071
461 ABNORMAL WEIGHT GAIN 88 0.0071
462 CONSTIPATION 1550 0.0071
463 WEIGHT INCREASED 1585 0.0071
464 JOINT SWELLING 854 0.0071
465 INCREASED APPETITE 135 0.0071
466 INITIAL INSOMNIA 72 0.0070
467 ATELECTASIS 67 0.0069
468 TACHYPNOEA 94 0.0069
469 PARAESTHESIA 1086 0.0069
470 SKIN LACERATION 75 0.0069
471 MOOD ALTERED 188 0.0069
472 MASS 96 0.0069
473 VENTRICULAR EXTRASYSTOLES 71 0.0068
474 FACIAL PARALYSIS 58 0.0068
475 FEAR 183 0.0068
476 APHASIA 204 0.0067
477 HEPATOTOXICITY 150 0.0067
478 PRODUCT PRESCRIBING ERROR 160 0.0067
479 SCIATICA 107 0.0067
480 GASTROOESOPHAGEAL REFLUX DISEASE 540 0.0067
481 HEAD INJURY 212 0.0067
482 CONDITION AGGRAVATED 2033 0.0067
483 DYSSTASIA 195 0.0067
484 EOSINOPHILIA 117 0.0067
485 HEAVY MENSTRUAL BLEEDING 60 0.0067
486 CYSTITIS 211 0.0066
487 TEMPERATURE INTOLERANCE 68 0.0066
488 PANCREATITIS ACUTE 148 0.0066
489 THIRST 117 0.0065
490 MUSCLE TIGHTNESS 106 0.0065
491 BOWEL MOVEMENT IRREGULARITY 50 0.0065
492 LETHARGY 375 0.0065
493 DYSTONIA 126 0.0065
494 PRODUCT USE IN UNAPPROVED INDICATION 1608 0.0065
495 PHOTOSENSITIVITY REACTION 107 0.0065
496 RHEUMATOID ARTHRITIS 731 0.0064
497 ABDOMINAL PAIN 1497 0.0064
498 UPPER-AIRWAY COUGH SYNDROME 53 0.0064
499 CARPAL TUNNEL SYNDROME 90 0.0064
500 ARRHYTHMIA 304 0.0064
501 DIZZINESS 3200 0.0064
502 ORAL PAIN 143 0.0064
503 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 454 0.0064
504 INTERVERTEBRAL DISC DEGENERATION 59 0.0064
505 REBOUND EFFECT 72 0.0064
506 HYPOKALAEMIA 294 0.0064
507 KNEE ARTHROPLASTY 134 0.0064
508 LEUKOCYTOSIS 115 0.0063
509 EXOSTOSIS 58 0.0063
510 MUSCULOSKELETAL STIFFNESS 556 0.0063
511 HEADACHE 3971 0.0063
512 ANKLE FRACTURE 98 0.0063
513 SPUTUM DISCOLOURED 60 0.0063
514 ABNORMAL BEHAVIOUR 250 0.0063
515 RETINAL DETACHMENT 58 0.0063
516 SLUGGISHNESS 64 0.0063
517 GASTRITIS 165 0.0063
518 CENTRAL NERVOUS SYSTEM LESION 86 0.0063
519 NECK PAIN 349 0.0062
520 PULMONARY THROMBOSIS 68 0.0062
521 SECRETION DISCHARGE 78 0.0062
522 EMOTIONAL DISORDER 192 0.0062
523 VISION BLURRED 855 0.0062
524 NERVOUSNESS 325 0.0062
525 EATING DISORDER 132 0.0062
526 ACCIDENTAL OVERDOSE 226 0.0062
527 VITAMIN D DEFICIENCY 60 0.0061
528 SUBDURAL HAEMATOMA 88 0.0061
529 PALPITATIONS 719 0.0061
530 OSTEOARTHRITIS 260 0.0061
531 HEPATIC CIRRHOSIS 115 0.0061
532 GLOMERULAR FILTRATION RATE DECREASED 75 0.0061
533 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 157 0.0061
534 MEDICATION ERROR 339 0.0061
535 THROMBOCYTOPENIA 682 0.0061
536 TOOTH ABSCESS 62 0.0061
537 DYSURIA 224 0.0061
538 AGRANULOCYTOSIS 113 0.0061
539 ORAL CANDIDIASIS 80 0.0061
540 MUSCULOSKELETAL CHEST PAIN 94 0.0061
541 IRRITABLE BOWEL SYNDROME 130 0.0061
542 DERMATITIS ALLERGIC 76 0.0060
543 WEIGHT FLUCTUATION 63 0.0060
544 BEDRIDDEN 79 0.0060
545 TARDIVE DYSKINESIA 169 0.0060
546 DEVELOPMENTAL DELAY 54 0.0060
547 HYPOPHAGIA 153 0.0060
548 THERAPY PARTIAL RESPONDER 93 0.0060
549 INTERVERTEBRAL DISC PROTRUSION 130 0.0059
550 SEASONAL ALLERGY 84 0.0059
551 FEELING ABNORMAL 1421 0.0059
552 MATERNAL EXPOSURE DURING PREGNANCY 528 0.0059
553 NAUSEA 4685 0.0059
554 CYANOSIS 93 0.0059
555 PSORIASIS 771 0.0059
556 SHOCK HAEMORRHAGIC 48 0.0059
557 NEURALGIA 143 0.0059
558 SCRATCH 62 0.0059
559 HAIR COLOUR CHANGES 73 0.0059
560 NERVE COMPRESSION 54 0.0058
561 HEART RATE IRREGULAR 132 0.0058
562 HYPERSENSITIVITY 1082 0.0058
563 HYPERKALAEMIA 204 0.0058
564 DRUG RESISTANCE 149 0.0058
565 GAIT DISTURBANCE 1104 0.0058
566 ELECTROLYTE IMBALANCE 67 0.0058
567 DECREASED ACTIVITY 62 0.0057
568 CONTUSION 553 0.0057
569 DYSPEPSIA 565 0.0057
570 ECONOMIC PROBLEM 87 0.0057
571 COLD SWEAT 101 0.0057
572 FEELING HOT 351 0.0057
573 ACUTE RESPIRATORY FAILURE 110 0.0057
574 TOOTH FRACTURE 63 0.0057
575 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 97 0.0057
576 SKIN INFECTION 64 0.0057
577 FOOT FRACTURE 108 0.0057
578 FATIGUE 4433 0.0057
579 GAMMA-GLUTAMYLTRANSFERASE INCREASED 126 0.0057
580 MYALGIA 966 0.0057
581 EYELID OEDEMA 66 0.0057
582 JOINT DISLOCATION 60 0.0057
583 PRODUCT ADMINISTRATION ERROR 114 0.0056
584 DECREASED APPETITE 1310 0.0056
585 FEELING COLD 157 0.0056
586 HYPOTHYROIDISM 180 0.0056
587 CHILLS 657 0.0056
588 FISTULA 63 0.0056
589 TUBULOINTERSTITIAL NEPHRITIS 105 0.0056
590 MOTOR DYSFUNCTION 57 0.0056
591 TENDERNESS 58 0.0056
592 HIATUS HERNIA 72 0.0056
593 BLOOD POTASSIUM DECREASED 167 0.0055
594 VOMITING 2608 0.0055
595 BLOOD TRIGLYCERIDES INCREASED 98 0.0055
596 CHOKING 108 0.0055
597 HYPOAESTHESIA 822 0.0055
598 FAECES DISCOLOURED 119 0.0055
599 HYPOXIA 193 0.0055
600 PULMONARY OEDEMA 245 0.0055
601 HAIR TEXTURE ABNORMAL 73 0.0055
602 RENAL FAILURE 724 0.0054
603 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 52 0.0054
604 GAIT INABILITY 182 0.0054
605 TRANSAMINASES INCREASED 121 0.0054
606 ASTHENIA 2043 0.0054
607 LYMPHOCYTE COUNT DECREASED 96 0.0054
608 MADAROSIS 63 0.0054
609 BLOOD CHOLESTEROL INCREASED 253 0.0054
610 BACK INJURY 59 0.0054
611 WHITE BLOOD CELL COUNT INCREASED 208 0.0054
612 C-REACTIVE PROTEIN INCREASED 195 0.0054
613 BLOOD SODIUM DECREASED 101 0.0054
614 INTENTIONAL DRUG MISUSE 112 0.0054
615 HAEMATOCHEZIA 295 0.0053
616 WEIGHT DECREASED 1492 0.0053
617 DYSPNOEA EXERTIONAL 201 0.0053
618 INTENTIONAL PRODUCT USE ISSUE 467 0.0053
619 LIVER FUNCTION TEST ABNORMAL 155 0.0053
620 CAESAREAN SECTION 62 0.0053
621 PRODUCTIVE COUGH 254 0.0053
622 PHARYNGEAL SWELLING 52 0.0053
623 PRODUCT USE ISSUE 994 0.0053
624 WHEEZING 313 0.0053
625 FEEDING DISORDER 107 0.0053
626 CANDIDA INFECTION 89 0.0053
627 EAR DISCOMFORT 54 0.0053
628 ABDOMINAL PAIN LOWER 133 0.0053
629 LIVER INJURY 129 0.0053
630 INFLAMMATION 271 0.0052
631 MUSCULAR WEAKNESS 595 0.0052
632 GENERAL PHYSICAL HEALTH DETERIORATION 605 0.0052
633 OFF LABEL USE 4575 0.0052
634 SEPSIS 582 0.0052
635 OSTEOPENIA 79 0.0052
636 HYPOCALCAEMIA 98 0.0052
637 INTESTINAL OBSTRUCTION 195 0.0052
638 NASAL CONGESTION 304 0.0052
639 UVEITIS 70 0.0052
640 TOOTH INFECTION 68 0.0052
641 BLOOD PRESSURE ABNORMAL 102 0.0051
642 DEMENTIA 143 0.0051
643 ARTHRITIS 402 0.0051
644 JOINT STIFFNESS 134 0.0051
645 DEHYDRATION 680 0.0051
646 ABDOMINAL DISCOMFORT 852 0.0051
647 BACK PAIN 1180 0.0051
648 LIMB DISCOMFORT 157 0.0051
649 GASTROENTERITIS 74 0.0051
650 DENTAL CARIES 56 0.0051
651 BLOOD IRON DECREASED 60 0.0051
652 FOOT DEFORMITY 56 0.0050
653 IMPAIRED DRIVING ABILITY 57 0.0050
654 ILEUS 62 0.0050
655 THERAPY CHANGE 49 0.0050
656 HYPERCHOLESTEROLAEMIA 48 0.0050
657 SCAR 85 0.0050
658 BODY HEIGHT DECREASED 53 0.0050
659 ABSCESS 79 0.0049
660 ARTHROPATHY 275 0.0049
661 NERVE INJURY 55 0.0049
662 NOCTURIA 60 0.0049
663 UPPER LIMB FRACTURE 98 0.0049
664 BRONCHITIS 364 0.0049
665 MALNUTRITION 55 0.0049
666 URINARY TRACT INFECTION 835 0.0049
667 LEUKOPENIA 243 0.0049
668 EMPHYSEMA 49 0.0049
669 DISCOMFORT 296 0.0048
670 FREQUENT BOWEL MOVEMENTS 131 0.0048
671 PULMONARY FIBROSIS 93 0.0048
672 AMENORRHOEA 85 0.0048
673 DYSPHAGIA 460 0.0048
674 BLOOD PRESSURE DECREASED 322 0.0048
675 ARTHRALGIA 2007 0.0048
676 PULMONARY EMBOLISM 458 0.0048
677 PYREXIA 1664 0.0048
678 PERIPHERAL SWELLING 740 0.0048
679 MALAISE 2106 0.0048
680 PARAESTHESIA ORAL 69 0.0048
681 RESPIRATORY FAILURE 348 0.0048
682 HYPERLIPIDAEMIA 57 0.0048
683 PHARYNGITIS 59 0.0048
684 BLOOD COUNT ABNORMAL 72 0.0047
685 COUGH 1329 0.0047
686 MUCOSAL INFLAMMATION 124 0.0047
687 MOBILITY DECREASED 340 0.0047
688 EYELID PTOSIS 48 0.0047
689 HAEMORRHOIDS 92 0.0047
690 ABDOMINAL PAIN UPPER 969 0.0047
691 OSTEOPOROSIS 193 0.0047
692 MUSCLE SPASMS 860 0.0047
693 JOINT INJURY 100 0.0047
694 BASAL CELL CARCINOMA 73 0.0047
695 POLYNEUROPATHY 56 0.0047
696 CLOSTRIDIUM DIFFICILE INFECTION 102 0.0047
697 VISUAL IMPAIRMENT 578 0.0047
698 TREATMENT NONCOMPLIANCE 255 0.0047
699 WOUND 130 0.0046
700 PANCREATITIS 245 0.0046
701 MULTIPLE SCLEROSIS 221 0.0046
702 RENAL INJURY 137 0.0046
703 SPINAL PAIN 54 0.0046
704 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 240 0.0046
705 LYMPHOPENIA 65 0.0046
706 WRIST FRACTURE 55 0.0046
707 CARDIAC FAILURE 367 0.0046
708 GOUT 82 0.0046
709 CELLULITIS 230 0.0046
710 DIARRHOEA 2938 0.0045
711 SPINAL FRACTURE 91 0.0045
712 DYSPNOEA 2566 0.0045
713 INTERSTITIAL LUNG DISEASE 219 0.0045
714 ACCIDENT 54 0.0045
715 THERAPY CESSATION 232 0.0045
716 INFECTION 653 0.0045
717 ORAL HERPES 88 0.0045
718 DRUG INEFFECTIVE 5934 0.0045
719 RHINORRHOEA 291 0.0045
720 OROPHARYNGEAL PAIN 413 0.0045
721 RECTAL HAEMORRHAGE 191 0.0044
722 HAEMATOCRIT DECREASED 88 0.0044
723 PAIN 2721 0.0044
724 ADVERSE DRUG REACTION 394 0.0044
725 PLATELET COUNT INCREASED 57 0.0044
726 MUSCLE ATROPHY 55 0.0043
727 FACE OEDEMA 73 0.0043
728 RASH MACULO-PAPULAR 96 0.0043
729 TENDON RUPTURE 53 0.0043
730 POLLAKIURIA 179 0.0043
731 COAGULOPATHY 71 0.0043
732 TOOTHACHE 77 0.0042
733 IMMUNE SYSTEM DISORDER 56 0.0042
734 HAEMATOMA 110 0.0042
735 ACTIVITIES OF DAILY LIVING IMPAIRED 84 0.0042
736 DIABETES MELLITUS 323 0.0042
737 ANGINA PECTORIS 121 0.0042
738 ALANINE AMINOTRANSFERASE INCREASED 259 0.0042
739 CHEST PAIN 781 0.0042
740 HAEMORRHAGE INTRACRANIAL 63 0.0042
741 SINUSITIS 431 0.0042
742 ILLNESS 433 0.0042
743 CHOLECYSTITIS 50 0.0042
744 SKIN LESION 115 0.0042
745 CONVULSION 238 0.0042
746 UPPER GASTROINTESTINAL HAEMORRHAGE 70 0.0042
747 THYROID DISORDER 64 0.0041
748 ROAD TRAFFIC ACCIDENT 173 0.0041
749 BACTERIAL INFECTION 77 0.0041
750 LOWER LIMB FRACTURE 79 0.0041
751 BLOOD ALKALINE PHOSPHATASE INCREASED 102 0.0041
752 GINGIVAL BLEEDING 56 0.0041
753 GASTROINTESTINAL DISORDER 366 0.0041
754 HEMIPARESIS 69 0.0041
755 SINUS CONGESTION 55 0.0041
756 INFLUENZA LIKE ILLNESS 335 0.0041
757 ABDOMINAL DISTENSION 424 0.0041
758 NEUTROPHIL COUNT DECREASED 165 0.0040
759 PSORIATIC ARTHROPATHY 164 0.0040
760 COLITIS 153 0.0040
761 LIMB INJURY 109 0.0040
762 ASPARTATE AMINOTRANSFERASE INCREASED 213 0.0040
763 MUSCULOSKELETAL PAIN 210 0.0040
764 METASTASES TO LIVER 70 0.0040
765 NASOPHARYNGITIS 733 0.0040
766 LOCALISED INFECTION 96 0.0040
767 VIRAL INFECTION 132 0.0040
768 HERPES ZOSTER 227 0.0039
769 GLAUCOMA 76 0.0039
770 ADVERSE REACTION 52 0.0039
771 COVID-19 687 0.0039
772 DRY EYE 195 0.0039
773 SKIN CANCER 84 0.0039
774 SMALL INTESTINAL OBSTRUCTION 48 0.0039
775 PAIN IN EXTREMITY 1147 0.0039
776 STAPHYLOCOCCAL INFECTION 128 0.0039
777 BACK DISORDER 63 0.0039
778 HYPERTHYROIDISM 56 0.0039
779 GALLBLADDER DISORDER 69 0.0039
780 MELAENA 85 0.0039
781 FLATULENCE 219 0.0039
782 DRUG EFFECT LESS THAN EXPECTED 57 0.0038
783 EAR INFECTION 102 0.0038
784 PULMONARY MASS 57 0.0038
785 DISEASE RECURRENCE 182 0.0038
786 KIDNEY INFECTION 75 0.0038
787 AGEUSIA 95 0.0038
788 PNEUMONIA 1232 0.0038
789 DISABILITY 75 0.0038
790 PAIN IN JAW 107 0.0038
791 GASTROENTERITIS VIRAL 68 0.0038
792 INFLUENZA 420 0.0038
793 MULTIPLE SCLEROSIS RELAPSE 258 0.0038
794 SKIN ULCER 97 0.0037
795 TOOTH DISORDER 83 0.0037
796 HYPOAESTHESIA ORAL 56 0.0037
797 RED BLOOD CELL COUNT DECREASED 106 0.0037
798 TRANSIENT ISCHAEMIC ATTACK 125 0.0037
799 EPISTAXIS 277 0.0037
800 ISCHAEMIC STROKE 66 0.0037
801 PRURITUS 1415 0.0037
802 DIVERTICULITIS 102 0.0037
803 THERAPEUTIC RESPONSE UNEXPECTED 165 0.0037
804 BONE DISORDER 67 0.0037
805 CORONARY ARTERY OCCLUSION 50 0.0036
806 ULCER 58 0.0036
807 PRODUCT DOSE OMISSION IN ERROR 103 0.0036
808 RASH 1581 0.0036
809 DRUG DEPENDENCE 579 0.0036
810 LYMPHADENOPATHY 127 0.0036
811 BURNING SENSATION 251 0.0036
812 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 645 0.0036
813 THERAPEUTIC PRODUCT EFFECT DECREASED 160 0.0036
814 RESPIRATORY TRACT INFECTION 93 0.0036
815 CHOLELITHIASIS 117 0.0036
816 PARALYSIS 51 0.0036
817 PANCYTOPENIA 199 0.0036
818 DISSEMINATED INTRAVASCULAR COAGULATION 50 0.0035
819 LIVER FUNCTION TEST INCREASED 76 0.0035
820 SEPTIC SHOCK 154 0.0035
821 BLOOD URINE PRESENT 67 0.0035
822 CATARACT 208 0.0035
823 ATRIAL FIBRILLATION 340 0.0035
824 FLUSHING 354 0.0035
825 OSTEOMYELITIS 63 0.0035
826 OEDEMA PERIPHERAL 424 0.0035
827 THROAT TIGHTNESS 94 0.0035
828 CEREBRAL HAEMORRHAGE 124 0.0035
829 PNEUMONITIS 94 0.0034
830 ALOPECIA 677 0.0034
831 ANAEMIA 657 0.0034
832 ERYTHEMA 708 0.0034
833 THERAPEUTIC RESPONSE SHORTENED 114 0.0034
834 FRACTURE 65 0.0034
835 MUSCULOSKELETAL DISCOMFORT 59 0.0034
836 DYSGEUSIA 254 0.0034
837 CHROMATURIA 77 0.0034
838 HEPATITIS 87 0.0034
839 DEEP VEIN THROMBOSIS 220 0.0034
840 RESPIRATORY DISORDER 101 0.0034
841 RENAL IMPAIRMENT 283 0.0034
842 BLISTER 189 0.0034
843 SKIN DISORDER 112 0.0034
844 PLEURAL EFFUSION 202 0.0033
845 GASTRIC ULCER 63 0.0033
846 LUNG DISORDER 162 0.0033
847 BLOOD CREATININE INCREASED 214 0.0033
848 WHITE BLOOD CELL COUNT DECREASED 352 0.0032
849 BONE PAIN 190 0.0032
850 CHEST DISCOMFORT 331 0.0032
851 DRUG EFFECT INCOMPLETE 117 0.0032
852 THERAPEUTIC RESPONSE DECREASED 195 0.0032
853 PERICARDITIS 54 0.0032
854 LIP SWELLING 107 0.0032
855 DEAFNESS 84 0.0032
856 PRESCRIBED UNDERDOSE 64 0.0032
857 PREMATURE DELIVERY 51 0.0032
858 HEPATIC FAILURE 96 0.0032
859 ACUTE MYOCARDIAL INFARCTION 92 0.0031
860 URTICARIA 522 0.0031
861 SWELLING 291 0.0031
862 HEPATIC FUNCTION ABNORMAL 116 0.0031
863 FUNGAL INFECTION 103 0.0031
864 PALLOR 84 0.0031
865 PRODUCT DOSE OMISSION ISSUE 902 0.0031
866 OEDEMA 166 0.0031
867 TASTE DISORDER 62 0.0031
868 ERUCTATION 59 0.0030
869 RENAL FAILURE ACUTE 129 0.0030
870 THROAT IRRITATION 136 0.0030
871 INTENTIONAL DOSE OMISSION 86 0.0030
872 INTERNATIONAL NORMALISED RATIO INCREASED 86 0.0030
873 GLOSSODYNIA 67 0.0030
874 HIP FRACTURE 96 0.0030
875 ECZEMA 155 0.0030
876 NEEDLE ISSUE 86 0.0030
877 HAEMOGLOBIN DECREASED 302 0.0029
878 EMOTIONAL DISTRESS 356 0.0029
879 SYNOVITIS 53 0.0029
880 NEUROPATHY PERIPHERAL 279 0.0029
881 ANAPHYLACTIC REACTION 162 0.0029
882 UNDERDOSE 214 0.0029
883 PRODUCT PHYSICAL ISSUE 59 0.0029
884 SKIN FISSURES 57 0.0029
885 PRODUCT DOSE OMISSION 190 0.0029
886 HERNIA 56 0.0029
887 ABORTION SPONTANEOUS 116 0.0029
888 FEBRILE NEUTROPENIA 190 0.0029
889 GASTROINTESTINAL HAEMORRHAGE 238 0.0028
890 PRODUCT PRESCRIBING ISSUE 62 0.0028
891 COLITIS ULCERATIVE 127 0.0028
892 DIABETES MELLITUS INADEQUATE CONTROL 50 0.0028
893 EYE DISORDER 92 0.0028
894 RASH PRURITIC 151 0.0028
895 MUSCULOSKELETAL DISORDER 53 0.0028
896 ILL-DEFINED DISORDER 169 0.0028
897 DIABETIC KETOACIDOSIS 66 0.0027
898 CARDIAC FAILURE CONGESTIVE 219 0.0027
899 JAUNDICE 73 0.0027
900 TOOTH LOSS 56 0.0027
901 NEUTROPENIA 367 0.0027
902 CARDIAC DISORDER 252 0.0027
903 DRUG EFFECT DECREASED 145 0.0027
904 PERICARDIAL EFFUSION 62 0.0027
905 SKIN DISCOLOURATION 123 0.0027
906 PRODUCT AVAILABILITY ISSUE 60 0.0026
907 RASH MACULAR 92 0.0026
908 SNEEZING 59 0.0026
909 LUNG NEOPLASM MALIGNANT 108 0.0026
910 FEMUR FRACTURE 81 0.0026
911 MENORRHAGIA 51 0.0026
912 STOMATITIS 157 0.0026
913 STEVENS-JOHNSON SYNDROME 57 0.0026
914 HAEMORRHAGE 268 0.0026
915 UNEVALUABLE EVENT 193 0.0025
916 THERAPY INTERRUPTED 182 0.0025
917 PULMONARY HYPERTENSION 53 0.0025
918 LIVER DISORDER 112 0.0025
919 SINUS DISORDER 50 0.0025
920 ANAPHYLACTIC SHOCK 65 0.0025
921 GASTRIC DISORDER 86 0.0025
922 SURGERY 146 0.0025
923 INJURY 175 0.0025
924 IMPAIRED HEALING 81 0.0025
925 THROMBOSIS 196 0.0024
926 PRODUCT DISPENSING ERROR 53 0.0024
927 PRURITUS GENERALISED 52 0.0024
928 PLATELET COUNT DECREASED 253 0.0024
929 HYPOACUSIS 102 0.0024
930 SYSTEMIC LUPUS ERYTHEMATOSUS 84 0.0024
931 EYE SWELLING 88 0.0024
932 INJECTION SITE MASS 87 0.0024
933 LABORATORY TEST ABNORMAL 68 0.0023
934 GLYCOSYLATED HAEMOGLOBIN INCREASED 58 0.0023
935 DERMATITIS 48 0.0023
936 CARDIOVASCULAR DISORDER 58 0.0023
937 RENAL DISORDER 106 0.0023
938 ABASIA 56 0.0023
939 RASH PAPULAR 50 0.0022
940 HAEMOPTYSIS 62 0.0022
941 DEATH 1868 0.0022
942 MYOCARDIAL INFARCTION 378 0.0022
943 INJECTION SITE URTICARIA 53 0.0022
944 PROCEDURAL PAIN 59 0.0021
945 BLOOD GLUCOSE DECREASED 101 0.0021
946 DRUG DOSE OMISSION 345 0.0021
947 ADVERSE EVENT 192 0.0021
948 ACNE 157 0.0021
949 SKIN EXFOLIATION 172 0.0020
950 CEREBROVASCULAR ACCIDENT 343 0.0020
951 LACRIMATION INCREASED 61 0.0020
952 INCORRECT DOSE ADMINISTERED 454 0.0020
953 HOSPITALISATION 299 0.0019
954 BLOOD BILIRUBIN INCREASED 52 0.0019
955 EYE IRRITATION 110 0.0019
956 CORONARY ARTERY DISEASE 57 0.0019
957 OCULAR HYPERAEMIA 88 0.0019
958 DERMATITIS ATOPIC 96 0.0018
959 VISUAL ACUITY REDUCED 59 0.0018
960 INJECTION SITE SWELLING 135 0.0018
961 INJECTION SITE REACTION 121 0.0018
962 DISEASE PROGRESSION 208 0.0018
963 INJECTION SITE BRUISING 137 0.0017
964 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 122 0.0017
965 MALIGNANT NEOPLASM PROGRESSION 175 0.0017
966 INJECTION SITE PRURITUS 114 0.0017
967 PRODUCT QUALITY ISSUE 230 0.0017
968 PLASMA CELL MYELOMA 66 0.0017
969 WRONG TECHNIQUE IN DRUG USAGE PROCESS 61 0.0017
970 EYE PRURITUS 56 0.0017
971 NEOPLASM PROGRESSION 57 0.0016
972 DEVICE ISSUE 146 0.0016
973 BLOOD GLUCOSE INCREASED 306 0.0016
974 BREAST CANCER 149 0.0016
975 BONE DENSITY DECREASED 50 0.0016
976 VAGINAL HAEMORRHAGE 69 0.0016
977 DRY SKIN 204 0.0015
978 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 307 0.0015
979 DRUG EXPOSURE DURING PREGNANCY 51 0.0015
980 DEVICE DISLOCATION 65 0.0015
981 INJECTION SITE PAIN 451 0.0015
982 EXTRA DOSE ADMINISTERED 59 0.0015
983 INJECTION SITE ERYTHEMA 179 0.0014
984 DEVICE BREAKAGE 58 0.0014
985 NEOPLASM MALIGNANT 93 0.0014
986 SKIN BURNING SENSATION 89 0.0012
987 DEPENDENCE 66 0.0012
988 INJECTION SITE HAEMORRHAGE 94 0.0012
989 SKIN IRRITATION 50 0.0011
990 DEVICE MALFUNCTION 68 0.0010
991 ACCIDENTAL EXPOSURE TO PRODUCT 91 0.0009
992 NO ADVERSE EVENT 134 0.0007